Product Data Sheet

CRBN ligand-302

Catalog No. A81088

main product photo
CRBN ligand-302 is a ligand for the E3 ubiquitin ligase cereblon (CRBN), facilitating targeted protein degradation through the recruitment of CRBN. This compound can be conjugated to a target protein ligand via a linker to form a PROTAC, enabling selective degradation of specific proteins. Its applications extend to studies in drug discovery, cancer research, and functional proteomics.
Chemical Information
Catalog NumA81088
M. Wt257.25
FormulaC12H11N5O2
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2925102-74-3
Synonyms
SMILESO=C1NC(=O)CCN1C=2C=CC=3C(=NC=NC3C2)N
Biological Activity
DescriptionCRBN ligand-302 is a ligand for the E3 ubiquitin ligase cereblon (CRBN), facilitating targeted protein degradation through the recruitment of CRBN. This compound can be conjugated to a target protein ligand via a linker to form a PROTAC, enabling selective degradation of specific proteins. Its applications extend to studies in drug discovery, cancer research, and functional proteomics.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.